On November 4, 2020, Shenzhen Lifotronic Co., Ltd. (hereinafter referred to as Lifotronic ) and Chongqing Jingyu Laser Technology Co., Ltd. (hereinafter referred to as Jingyu Laser) held an equity investment signing ceremony in Lifotronic Songshanhu manufacturing base, and Lifotronic became the absolute controlling shareholder of Jingyu Laser.
Mr. Liu Xiancheng, Chairman of Lifotronic, and Mr. Liao Zheng, the shareholder representative of Jingyu Laser, attended the signing ceremony. After the signing ceremony, the two sides conducted extensive and in-depth conversation on how to integrate resources and coordinate development of key businesses such as product research and development, manufacturing, marketing, and user services.
As an innovator of photon therapy technology, Lifotronic has focused on deep cultivation of skin and wounds in the past ten years, established a nationwide marketing channel network, and accumulated a large number of user groups. The product performance and service quality of Lifotronic products are widely praised all over the world!
Jingyu Laser is the first manufacturer in China obtained the registration certificate of Q-switched laser (Nd:YAG) therapeutic device. Its laser products cover pulse, Q-switched and other mainstream technology types, with stable product performance and reliable quality. Through this equity investment, Lifotronic will apply its comprehensive advantages in R&D, quality control, supply chain and marketing to integrate resources, and integrate the full line of laser treatment products under Jingyu Laser into Lifotronic domestic and foreign marketing. In this way, Lifotronic's treatment and rehabilitation product line is greatly enriched, providing customers with more complete skin and wound treatment solutions.